Evidence map›Paper›PMID 38117783›Full record

ArticlePLOS global public health2023

The effect of M. tuberculosis lineage on clinical phenotype.

Duc Hong Du, Ronald B Geskus, Yanlin Zhao, Luigi Ruffo Codecasa, Daniela Maria Cirillo, Reinout van Crevel, Dyshelly Nurkartika Pascapurnama, Lidya Chaidir, Stefan Niemann, Roland Diel and 14 more

Erratum issuedAbstract read
In one paragraph

Article in PLOS global public health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed.

  1. Article
  2. Article
  3. Population structure and spatial distribution ofFrontiers in microbiology · 2026
    Article
  4. Host- and pathogen-related determinants of pulmonaryEuropean respiratory review : an official journal of the European Respiratory Society · 2026
    Review
  5. Review
  6. Article
  7. Observational
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Experimental dissection of tuberculosis protective immunity: a human perspective.Frontiers in cellular and infection microbiology · 2025
    Review
  15. Article
  16. Article
  17. Genetic Diversity ofPathogens (Basel, Switzerland) · 2024
    Article
  18. Article
  19. Multidrug-resistant tuberculosis.Nature reviews. Disease primers · 2024
    Review
  20. The chosen few:Frontiers in immunology · 2024
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

24 authors.

Duc Hong DuOxford University Clinical Research Unit, Ho Chi Minh City, Vietnam.ORCID https://orcid.org/0000-0002-9181-3386
Ronald B GeskusOxford University Clinical Research Unit, Ho Chi Minh City, Vietnam.
Yanlin ZhaoCDC China, Beijing, China.ORCID https://orcid.org/0000-0002-7890-4312
Luigi Ruffo CodecasaRegional TB Reference Centre/ Istituto Villa Marelli- ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy.ORCID https://orcid.org/0000-0001-6825-2050
Daniela Maria CirilloIRCCS San Raffaele Scientific Institute, Milano, Italy.ORCID https://orcid.org/0000-0001-6415-1535
Reinout van CrevelCentre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.
Dyshelly Nurkartika PascapurnamaResearch Center for Care and Control of Infectious Diseases, Universitas Padjadjaran, Sumedang, West Java, Indonesia.
Lidya ChaidirDepartment of Biomedical Sciences, Faculty of Medicine, Universitas Padjadjaran, Sumedang, West Java, Indonesia.
Stefan NiemannResearch Center Borstel, Borstel, Germany.
Roland DielUniversity Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany.ORCID https://orcid.org/0000-0001-8304-7709
Shaheed Vally OmarNICD, Johannesburg, South Africa.
Louis GrandjeanUniversity College London Hospital, London, United Kingdom.
Sakib RokadiyaUniversity College London Hospital, London, United Kingdom.
Arturo Torres OrtitzUniversity College London Hospital, London, United Kingdom.
Nguyễn Hữu LânPham Ngoc Thach Hospital, Ho Chi Minh City, Vietnam.
Đặng Thị Minh HàPham Ngoc Thach Hospital, Ho Chi Minh City, Vietnam.
E Grace SmithTB Unit and National Mycobacterial Reference Service, UK Health Security Agency, Birmingham, United Kingdom.
Esther RobinsonTB Unit and National Mycobacterial Reference Service, UK Health Security Agency, Birmingham, United Kingdom.
Martin DedicoatTB Unit and National Mycobacterial Reference Service, UK Health Security Agency, Birmingham, United Kingdom.
Le Thanh Hoang NhatOxford University Clinical Research Unit, Ho Chi Minh City, Vietnam.
Guy E ThwaitesOxford University Clinical Research Unit, Ho Chi Minh City, Vietnam.
Le Hong VanOxford University Clinical Research Unit, Ho Chi Minh City, Vietnam.
Nguyen Thuy Thuong ThuongOxford University Clinical Research Unit, Ho Chi Minh City, Vietnam.
Timothy M WalkerOxford University Clinical Research Unit, Ho Chi Minh City, Vietnam.ORCID https://orcid.org/0000-0003-0421-9264

Funding

Using the Mycobacterium tuberculosis Genome to Predict Tuberculosis Pathology, Drug Resistance Acquisition and Identify Community Transmission SitesR01AI146338 · NIAID · JOHNS HOPKINS UNIVERSITY · PI GILMAN, ROBERT H · 2020 to 2024
$3.3M
NIAID NIH HHS R01 AI146338Wellcome Trust
6 · The paper itself

Abstract

Six lineages of Mycobacterium tuberculosis sensu stricto (which excludes M. africanum) are described. Single-country or small observational data suggest differences in clinical phenotype between lineages. We present strain lineage and clinical phenotype data from 12,246 patients from 3 low-incidence and 5 high-incidence countries. We used multivariable logistic regression to explore the effect of lineage on site of disease and on cavities on chest radiography, given pulmonary TB; multivariable multinomial logistic regression to investigate types of extra-pulmonary TB, given lineage; and accelerated failure time and Cox proportional-hazards models to explore the effect of lineage on time to smear and culture-conversion. Mediation analyses quantified the direct effects of lineage on outcomes. Pulmonary disease was more likely among patients with lineage(L) 2, L3 or L4, than L1 (adjusted odds ratio (aOR) 1.79, (95% confidence interval 1.49-2.15), p<0.001; aOR = 1.40(1.09-1.79), p = 0.007; aOR = 2.04(1.65-2.53), p<0.001, respectively). Among patients with pulmonary TB, those with L1 had greater risk of cavities on chest radiography versus those with L2 (aOR = 0.69(0.57-0.83), p<0.001) and L4 strains (aOR = 0.73(0.59-0.90), p = 0.002). L1 strains were more likely to cause osteomyelitis among patients with extra-pulmonary TB, versus L2-4 (p = 0.033, p = 0.008 and p = 0.049 respectively). Patients with L1 strains showed shorter time-to-sputum smear conversion than for L2. Causal mediation analysis showed the effect of lineage in each case was largely direct. The pattern of clinical phenotypes seen with L1 strains differed from modern lineages (L2-4). This has implications for clinical management and could influence clinical trial selection strategies.

Identifiers

PMID38117783
PMCPMC10732390

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.